STAMPEDE Innovation Event

Hear about innovations and projects from across the prostate cancer community.

What's the event about?

This time, we'll be exploring the insights gained from the STAMPEDE trial and what it means for patients living longer with advanced prostate cancer. Register now to hear from our fantastic expert speakers, Noel Clarke and Ashwin Sachdeva.

Event details

Date: Wednesday 6 March, 2024

Time: 7:30-8:30pm

Location: Online, via Microsoft Teams

Register now

Meet the speakers

Professor Noel Clarke

Professor Noel Clarke is a Consultant Urological Surgeon and Clinician Scientist. He manages complex urological cancer surgery and plans and coordinates studies in urological cancer through basic/translational science and clinical trials. Surgically, he specialises in secondary and tertiary referral complex pelvic and retroperitoneal cancers, dealing with high volume complex urological malignancies and rare abdomino-pelvic tumours. In prostate cancer research and treatment he leads the GU research and FASTMAN prostate cancer research teams at The Christie / University of Manchester Cancer Research Institute, one of the largest prostate cancer research groups in the UK. In trials he is Co-PI of the STAMPEDE and RADICALS trials and jointly coordinates other international studies (Propel, Patch, IceCaP, StopCaP). He is the joint clinical lead for the National Prostate Cancer Audit (www.npca.org) in England and Wales. He has published over 295 peer reviewed scientific papers and co-authored 9 book chapters on urological cancer and its management.

Dr Ashwin Sachdeva

Dr Ashwin Sachdeva is a National Institute of Health and Care Research Academic Clinical Lecturer in Urology at the University of Manchester and The Christie Hospital. Ashwin has a special interest in translational prostate cancer research and has won the prestigious Prostate Cancer Foundation Young Investigator Award to support his innovative work linking trial data with imaging and routinely collected health data as part of the world-leading STAMPEDE trial. This work will investigate treatment toxicity in advanced prostate cancer and the potential approaches to minimise these side-effects.

Ashwin Sachdeva — Research Explorer The University of Manchester

Agenda

Watch this space for more information about the event...

Do you have an exciting innovation or project to share?

If you'd like to share a project or innovation that you've led on, which has improved the prostate cancer pathway for men, please do get in touch

We're interested in hearing about projects including (but not limited to): 

  • Prostate cancer risk awareness campaigns 
  • Diagnosing prostate cancer earlier, e.g., the faster diagnostic standard, optimal timed pathway for prostate cancer and rapid diagnostics 
  • Nurse-led triage 
  • Implementation of mpMRI and LATP biopsy 
  • Personalised care and supported self-management